Skip to content

Public FDA record

Z-0204-2016: Philips HeartStart MRx Monitor/Defibrillators Models: M3535A and M3536A

Recall record Z-0204-2016 for Philips Medical Systems, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0204-2016
Company in FDA record
Philips Medical Systems, Inc.
FDA classification date
Nov 3, 2015
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

1. Device will perform the weekly automated tests hourly, which could cause the therapy capacitors to degrade sooner than intended and 2. While connected to AC or DC power and with no battery installed or the battery installed has a charge level of less than 10%, the Ready for Use (RFU) indicator will not provide the expected low battery indication

Source facts

Action
Philips Healthcare sent an " Urgent Field Safety Notice " dated November 2014, to all affected customers. The letter identified the product the problem and the action needed to be taken by the customer. A hardware upgrade will be provided free of charge for all units affected by this issue. A Philips Healthcare representative will contact customers with affected devices to arrange for installation of the upgrade. Philips is asking customers to follow the Action to be Taken by Customer/User section of the Urgent Medical Device Correction notification/Field Safety Notice: A Philips authorized service provider will service the device and ensure it is operating within specification. Prior to receiving service, you can continue to use your MRx provided that the following steps are followed. These steps will prevent further accelerated degradation of the therapy capacitor, and will eliminate the above described behavior for no/low battery conditions. To correct the problem, set the configuration of the MRx to factory defaults in configuration mode. Please contact your local Philips Service Representative for further questions, or call (978) 687-1501.
Initiated
2014-11-19
Root cause
Process control
Terminated
2016-08-15
Distribution
Worldwide Distribution - USA (nationwide), Australia, Austria, Bahrain, Belgium, Brunei Darussalam, Canada, China, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Republic of Korea, Libyan Arab Jamahiriya, Lithuania, Mexico, Namibia, Netherlands, Palestine, Philippines, Poland, Portugal, Qatar, Russian Federation, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Taiwan, United Arab Emirates and United Kingdom.
Recall number
Z-0204-2016
Recall status
Terminated
CDRH record ID
131406
FDA classified
2015-11-03
Recall event number
69712

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗